Skip to main content

Find Clinical Trials

Home
Conditions
Brain Diseases, Metabolic

Clinical trial condition

Brain Diseases, Metabolic

Explore clinical trials studying Brain Diseases, Metabolic. Study availability and eligibility vary by location and protocol.

1,103 public trials 225 recruiting studies

Refine in advanced search Browse all conditions

Brain Diseases, Metabolic trial results

Completed

A Switch-Over Study of the Safety and Efficacy of ISU302 in Patients With Type 1 Gaucher Disease

NCT02053896

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations: Not specified

View Trial Details

Completed

Probiotic Lactobacillus GG (LGG) in Patients With Minimal Hepatic Encephalopathy

NCT00992290

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +12 more
Locations: Virginia Commonwealth University Richmond, Virginia, United States

View Trial Details

Completed

Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic Preparation

NCT01110447

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +8 more
Locations: Dept. of Hepatology, PGIMER Chandigarh, India

View Trial Details

Completed

Branched Chain Aminoacid Supplementation in Patients With Liver Cirrhosis

NCT02023229

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +12 more
Locations: Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" Mexico City, Mexico

View Trial Details

Completed

A Study of the Safety and Efficacy of Fabrazyme (Agalsidase Beta) as Compared to Placebo in Patients With Advanced Fabry Disease

NCT00074984

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Cedars-Sinai Medical Center Los Angeles, California, United States

University of San Francisco San Francisco, California, United States

University of Connecticut Health Partners Farmington, Connecticut, United States

View all 26 locations

View Trial Details

Completed

A Study to Assess the Absorption, Metabolism and Excretion of Migalastat Hydrochloride (AT1001-014)

NCT01730482

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Not specified

View Trial Details

Completed

Migalastat Food Effect Study

NCT01489995

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: GSK Investigational Site Austin, Texas, United States

View Trial Details

Completed

A Phase I, Randomized, Single-Blind, Four-Period Cross-Over, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Single Oral Doses of GR181413A/AT1001 in Healthy Japanese Subjects

NCT01853852

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: GSK Investigational Site Randwick, New South Wales, Australia

View Trial Details

Completed

L-arginine Therapy on Endothelium-dependent Vasodilation & Mitochondrial Metabolism in MELAS Syndrome

NCT01603446

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +18 more
Locations: The Hospital for Sick Children Toronto, Ontario, Canada

View Trial Details

Completed

Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic Encephalopathy

NCT01559519

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +14 more
Locations: Not specified

View Trial Details